# 中国联通 vs EviMed

The clearest difference is rating: EviMed at 5.0 against 中国联通's 2.5. 中国联通's advantage is in-app purchases (none vs 10) and ratings volume (1.3K vs 1). On price, update cadence, ads and device support there is nothing between them.

Both are free to download. EviMed sells 10 one-off in-app purchases. 中国联通 asks for nothing beyond the download.

EviMed holds the better App Store score, 5.0 against 2.5. That said, the two scores are not equally well evidenced: 中国联通 has 1.3K ratings behind it against 1, so its average is the more settled of the two.

中国联通 ships an update every 3 weeks, EviMed every 2 weeks. The most recent releases landed on October 26, 2026 and October 14, 2026 respectively.

## The numbers

| Metric | 中国联通 | EviMed |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [2.5 (1.3K ratings)](https://appshunter.io/ios/app/id416457422/reviews) | **[5.0 (1 ratings)](https://appshunter.io/ios/app/evimed/id1670527809/reviews)** |
| Number of ratings | **1.3K** | 1 |
| Positive reviews | 37.1% of reviews | — |
| In-app purchases | **No** | Yes |
| Ads | No | No |
| Update frequency | Every 3 weeks | **Every 2 weeks** |
| Monetization | — | Free with in-app purchases |
| Size | 333 MB | 70 MB |
| Requires iOS | 13.0 | 13 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 4+ | 17+ |
| Developer | [China United Network Communications Corporation Limited](https://appshunter.io/developer/674392285) | [灵犀量子(北京)医疗科技有限公司](https://appshunter.io/developer/1670309668) |

## What reviewers say

### 中国联通

[App page](https://appshunter.io/ios/app/id416457422)

**Features:** Vision Pro support

**In-app purchases:** none

**What reviewers like**

- 👍 Convenient app
- 🚀 Fast and responsive
- 💡 Comprehensive functionality

**What reviewers complain about**

- 🐛 Frequent crashes
- 🔋 High battery consumption
- 📢 Too many ads and promotions
- 🤯 Confusing and cluttered UI
- 🔒 Privacy concerns

**Reported bugs**

- Login issues and authentication problems
- Compatibility problems with newer OS versions
- Inconsistent performance across devices

**Requested features**

- Add English language support
- Improve search and navigation
- Provide more detailed account information
- Implement dark mode option


### EviMed

[App page](https://appshunter.io/ios/app/evimed/id1670527809)

This AI-powered tool searches and analyzes vast amounts of medical literature, guidelines, and drug information to provide evidence-based answers to clinical questions. It extracts key information and synthesizes knowledge to deliver qualitative and quantitative conclusions.

**Highlights:** Medical knowledge search engine, AI-powered evidence-based Q&A, Analysis of literature, guidelines, and drug data, Real-time updated global data, Information extraction and knowledge synthesis, Qualitative and quantitative conclusion generation

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases (10)**

| Purchase | Price | Billing |
| --- | --- | --- |
| 超级会员-基础版（月会员） | $39.99 | one-time |
| EviMed 药品遴选会员（月会员） | $59.99 | one-time |
| EviMed 药品遴选会员（季度） | $129.99 | one-time |
| 超级会员-专业版（月会员） | $149.99 | one-time |
| EviMed 药学联合会员（季度） | $199.99 | one-time |
| EviMed 药品遴选会员（半年度） | $299.99 | one-time |
| EviMed 药学联合会员（半年度） | $349.99 | one-time |
| EviMed 药品遴选会员（年度） | $399.99 | one-time |
| 超级会员-基础版（年会员） | $399.99 | one-time |
| 超级会员-旗舰版（月会员） | $399.99 | one-time |


## Frequently asked questions

### Is 中国联通 free?

中国联通 is free to download, with no in-app purchases.

### Is EviMed free?

EviMed is free to download, with in-app purchases available.

### Which has better reviews, 中国联通 or EviMed?

EviMed is rated higher. 中国联通 averages 2.5 out of 5 from 1.3K ratings, while EviMed averages 5.0 from 1 ratings.

### Do 中国联通 or EviMed have ads?

Neither 中国联通 nor EviMed shows ads.

### Which is updated more often, 中国联通 or EviMed?

中国联通 ships an update every 3 weeks, and EviMed every 2 weeks. Most recently, 中国联通 was updated on October 26, 2026 and EviMed on October 14, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*